Inari Medical Management
Management criteria checks 2/4
Inari Medical's CEO is Drew Hykes, appointed in Jan 2023, has a tenure of 1.5 years. total yearly compensation is $5.08M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth €17.97M. The average tenure of the management team and the board of directors is 2 years and 4.7 years respectively.
Key information
Drew Hykes
Chief executive officer
US$5.1m
Total compensation
| CEO salary percentage | 13.8% |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$24m |
| Dec 31 2023 | US$5m | US$700k | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$3m | US$500k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$22m |
| Jun 30 2022 | n/a | n/a | -US$15m |
| Mar 31 2022 | n/a | n/a | -US$758k |
| Dec 31 2021 | US$3m | US$450k | US$10m |
| Sep 30 2021 | n/a | n/a | US$16m |
| Jun 30 2021 | n/a | n/a | US$25m |
| Mar 31 2021 | n/a | n/a | US$17m |
| Dec 31 2020 | US$829k | US$384k | US$14m |
| Sep 30 2020 | n/a | n/a | US$7m |
| Jun 30 2020 | n/a | n/a | US$1m |
| Mar 31 2020 | n/a | n/a | US$4m |
| Dec 31 2019 | US$654k | US$316k | -US$1m |
Compensation vs Market: Drew's total compensation ($USD5.08M) is above average for companies of similar size in the German market ($USD2.13M).
Compensation vs Earnings: Drew's compensation has increased whilst the company is unprofitable.
CEO
Drew Hykes (51 yo)
1.5yrs
Tenure
US$5,083,365
Compensation
Mr. Andrew J. Hykes, also known as Drew, served as Chief Operating Officer at Inari Medical, Inc. since October 2020 until December 2022 and serves as its President and Director since January 2023 and serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.5yrs | US$5.08m | 0.66% $ 18.0m | |
| Chief Financial Officer | 5.3yrs | US$2.49m | 0.25% $ 6.7m | |
| Chief Medical Officer | 5yrs | US$2.50m | 0.50% $ 13.7m | |
| Senior Vice President of Operations | 1.4yrs | no data | no data | |
| Senior Vice President of Finance | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| General Counsel & Secretary | 3.7yrs | no data | no data | |
| Senior Vice President of Marketing | 4.6yrs | no data | no data | |
| Senior VP of Sales & Senior VP of U.S. Sales | less than a year | no data | no data | |
| Senior VP & GM of LimFlow | 2.5yrs | no data | no data | |
| Senior Vice President of Engineering | no data | no data | no data | |
| Chief Medical Officer of LimFlow | less than a year | no data | no data |
2.0yrs
Average Tenure
56yo
Average Age
Experienced Management: IM7's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.5yrs | US$5.08m | 0.66% $ 18.0m | |
| Independent Chair of the Board | 12.8yrs | US$266.47k | 5.31% $ 144.2m | |
| Independent Director | 12.8yrs | US$230.97k | 0.92% $ 25.1m | |
| Independent Director | 2.8yrs | US$218.47k | 0.011% $ 293.8k | |
| Independent Director | 4.7yrs | US$220.51k | 0.031% $ 854.8k | |
| Director | 9.4yrs | US$198.43k | 1.37% $ 37.3m | |
| Independent Director | 4.7yrs | US$235.93k | 0.059% $ 1.6m | |
| Independent Director | 2.3yrs | US$220.97k | 0.012% $ 325.0k | |
| Independent Director | 3.1yrs | US$220.93k | 0.0096% $ 259.6k |
4.7yrs
Average Tenure
57yo
Average Age
Experienced Board: IM7's board of directors are considered experienced (4.7 years average tenure).